The DOI matches its Crossref record.
Regulated expression and growth inhibitory effects of transforming growth factor-β isoforms in mouse mammary gland development
Abstract
Transforming Growth Factor-βl (TGF-β1) was pre-viously shown to inhibit reversibly the growth of mouse mammary ducts when administered in vivo by miniature slow-release plastic implants. We now report a compara-tive analysis of three TGF-β isoforms with respect to gene expression and localization of protein products within the mouse mammary gland. Our studies revealed overlapping expression patterns of TGF-β 1, TGF-β 2 and TGF-β 3 within the epithelium of the actively-growing mammary end buds during branching morpho-genesis, as well as within the epithelium of growth-quiescent ducts. However, TGF-J83 was the only isoform detected in myoepithelial progenitor cells (cap cells) of the growing end buds and myoepithelial cells of the mature ducts. During pregnancy, TGF-β2 and TGF-β 3 transcripts increased to high levels, in contrast to TGF-β1 transcripts which were moderately abundant; TGF-β2 was significantly transcribed only during pregnancy. Molecular hybridization in situ revealed overlapping patterns of expression for the three TGF-β isoforms during alveolar morphogenesis, but showed that, in contrast to the patterns of TGF-β1 and TGF-β2 expression, TGF-β3 is expressed more heavily in ducts than in alveoli during pregnancy. Developing alveolar tissue and its associated ducts displayed striking TGF-β3 immunoreactivity which was greatly reduced during lactation. All three isoforms showed dramatically reduced expression in lactating tissue. The biological effects of active, exogenous TGF-β 2 and TGF-β3 were tested with slow-release plastic implants. These isoforms, like TGF-β1, inhibited mam-mary ductal elongation in situ by causing the disappear-ance of the proliferating stem cell layer (cap cells) and rapid involution of ductal end buds. None of the isoforms were active in inhibiting alveolar morphogenesis. We conclude that under the limited conditions of these tests, the three mammalian isoforms are functionally equival-ent. However, striking differences in patterns of gene expression and in the distribution of immunoreactive peptides suggest that TGF-β isoforms may have distinct roles in mammary growth regulation, morphogenesis and functional differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.2021 · Cited by 937
Transforming growth factor–β3 is required for secondary palate fusion
Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P. N., Ding, J., Ferguson, M. W. J., & Doetschman, T. (1995) · Nature Genetics · doi:10.1038/ng1295-409 · Cited by 908
Lund, L. R., Rømer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Danø, K., & Werb, Z. (1996) · Development · doi:10.1242/dev.122.1.181 · Cited by 546
TGF-β – an excellent servant but a bad master
Kubiczkova, L., Sedlarikova, L., Hajek, R., & Sevcikova, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-183 · Cited by 511
Postnatal mammary gland development requires macrophages and eosinophils
Gouon-Evans, V., Rothenberg, M. E., & Pollard, J. W. (2000) · Development · doi:10.1242/dev.127.11.2269 · Cited by 468
Transforming growth factor-beta activation in irradiated murine mammary gland.
Barcellos-Hoff, M. H., Derynck, R., Tsang, M. L., & Weatherbee, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117045 · Cited by 431
Piek, E., Moustakas, A., Kurisaki, A., Heldin, C.-H., & Dijke, P. T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.24.4557 · Cited by 426
Bissell, D. M., Wang, S. S., Jarnagin, W. R., & Roll, F. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118055 · Cited by 419
Hormones and Growth Factors in Milk
GROSVENOR, C. E., PICCIANO, M. F., & BAUMRUCKER, C. R. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-6-710 · Cited by 417
Fata, J. E., Werb, Z., & Bissell, M. J. (2003) · Breast Cancer Research · doi:10.1186/bcr634 · Cited by 383
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Neel, J.-C., Humbert, L., & Lebrun, J.-J. (2012) · ISRN Molecular Biology · doi:10.5402/2012/381428 · Cited by 345
Cunha, G. R. (1994) · Cancer · doi:10.1002/1097-0142(19940801)74:3+<1030::aid-cncr2820741510>3.0.co;2-q · Cited by 328
Mammary tumor suppression by transforming growth factor beta 1 transgene expression.
Pierce, D. F., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J., & Moses, H. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4254 · Cited by 291
Extracellular matrix regulates expression of the TGF-beta 1 gene.
Streuli, C. H., Schmidhauser, C., Kobrin, M., Bissell, M. J., & Derynck, R. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.1.253 · Cited by 259
Upadhyay, G., Yin, Y., Yuan, H., Li, X., Derynck, R., & Glazer, R. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103441108 · Cited by 75
Flanders, K. C., Yang, Y.-A., Herrmann, M., Chen, J., Mendoza, N., Mirza, A. M., & Wakefield, L. M. (2016) · Oncotarget · doi:10.18632/oncotarget.9416 · Cited by 39
Self-citationTGF‐β promotes cell death and suppresses lactation during the second stage of mammary involution
Bierie, B., Gorska, A. E., Stover, D. G., & Moses, H. L. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21646 · Cited by 39
Hachim, M. Y., Hachim, I. Y., Dai, M., Ali, S., & Lebrun, J.-J. (2018) · Tumor Biology · doi:10.1177/1010428317748254 · Cited by 35
Metadata
- Authors
- Robinson, S. D., Silberstein, G. B., Roberts, A. B., Flanders, K. C., & Daniel, C. W.
- Venue
- Development
- Publisher
- The Company of Biologists
- Published
- 1991-11-01
- Volume
- 113
- Issue
- 3
- Pages
- 867-878
- ISSN
- 0950-1991 (ISSN-L)
- 1477-9129
- OpenAlex
- W2279922459
- Cited by
- 230
- References
- 0
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.